Niel Brown Joins the Sonio team as they expand into the US Healthcare Market
Sonio, the MedTech company specializing in women’s and children’s health, today announces the appointment of Niel Brown to the team as they continue to expand into the US maternal healthcare market.
Niel is joining as the Director of Operations in the US at Sonio. With over 25 years in the healthcare sector, Niel has extensive experience in implementing new healthcare systems, particularly in innovation in America’s maternal and fetal care industry.
“I am honored to have joined Sonio during this exciting and transformative time in healthcare,” says Niel Brown. “The opportunity to work alongside a team as dedicated in advancing maternal care as myself is truly inspiring. Together, we hope to make an impact across the US, ensuring families have access to the high-quality care they deserve.”
The news comes coupled with the announcement of the CEO and co-founder, Cecile Brosset’s, relocation from Sonio’s headquarters in Paris, France, to Boston. Cecile plans on working hands on with the US-based Sonio team to continue to expand in the US market.
“We are thrilled to welcome Niel to the team,” says Cecile Brosset, CEO and co-founder of Sonio. “His first-hand knowledge of Sonio Detect and extensive experience in the maternal care sector will be invaluable as we continue on our journey in the US market.”
Together, Niel and Cecile plan to work toward making maternal care more accessible to people across the US. Their combined expertise will continue to drive Sonio’s mission of revolutionizing maternal healthcare, ensuring better outcomes for mothers and children.
About Sonio:
Sonio is a highly customizable workflow and practice management solution powered by AI for automation, efficiency, and quality control. “Sonio AI-enhanced¹ software empowers ultrasound practitioners and readers. Sonio assists them in performing every prenatal examination to their highest quality standards, ensuring the completeness of each examination, streamlining their workflow, and in prenatal diagnosis. Sonio is based on over five years of research and collaboration between leading experts in fetal medicine and AI.
¹AI-enhancement is provided by FDA 510(k) cleared Sonio Detect product
* Applicable to V1 only, Data enclosed at Sonio
**See table 6 in the 510k summary: https://www.accessdata.fda.gov/cdrh_docs/pdf24/K240406.pdf
To learn more about Sonio, visit our website https://sonio.ai/
The Editorial Team at Healthcare Business Today is made up of experienced healthcare writers and editors, led by managing editor Daniel Casciato, who has over 25 years of experience in healthcare journalism. Since 1998, our team has delivered trusted, high-quality health and wellness content across numerous platforms.
Disclaimer: The content on this site is for general informational purposes only and is not intended as medical, legal, or financial advice. No content published here should be construed as a substitute for professional advice, diagnosis, or treatment. Always consult with a qualified healthcare or legal professional regarding your specific needs.
See our full disclaimer for more details.
